Tag Archives: CBD

The great race to become the World’s weed supplier

24818176-marijuana-laws-marijuana-plants-jpg

Submitted by Marijuana News on Fri, 10/11/2019

Companies vying to be the biggest cannabis producer in America or Canada are wasting their time and suffering from a crippling lack of vision. The real play is to make a bid to become the worldwide leader in global cannabis exports — like firms in Jamaica and Lesotho as well as Canada are attempting to do — and the window of time to get in is closing fast, according to one entrepreneur with clear-cut plans to curb that market.

Though recreational cannabis is now available in two countries, medical marijuana is legal in about 50 and not every country produces adequate supply to fulfill domestic demand. Over the long-term, the thinking goes, cannabis will become like any other agricultural commodity and production will shift to the locale where costs are lowest. But so far, the limited export game has been dominated by a few players, most of whom are either occupying a very limited lane or banking on the future.

An example of the former, Bedrocan in the Netherlands, produces cannabis solely for the government authority, which then exports most of it to Germany. Bophelo Bioscience and Wellness, a startup recently acquired by a Canadian-firm and based in tiny Lesotho, the first country in Africa to legalize cannabis, is an example of the latter. Somewhere else is a company like Fotmer Life Sciences in Uruguay, which is hoping to supplant both.

The world’s most popular illicit drug, cannabis boasts at least 263 million users worldwide, according to a New Frontier Data estimate, who in turn consume $340 billion worth annually, most of which is still on the underground market. At the moment, with so few legal companies producing cannabis and even fewer exporting, it’s a seller’s market. That state of play — flux, uncertainty, opportunity — will last only about another five years, said Jordan Lewis, an American entrepreneur who is Fotmer’s CEO.

Fotmer was in the news much last week as the company prepared its first shipment of export cannabis: 22 pounds, headed for medical cannabis patients in Australia. After that, Fotmer hopes to start competing with Bedrocan and begin shipping cannabis flower and oil to Germany, with up to 220 pounds or so per month headed out of the country to global customers, as he told Reuters.

Most of that will go to Europe, which “right now represents the single largest market in the next five years,” Lewis told Supplychainbrain.com.

The window for producers to charge high prices, before a reliable global supply floods the market, is now through 2024, he added, with high THC oils and plants to preserve their value longer than CBD products.

The modest first shipment is a tiny fraction of the company’s capacity. Fotmer currently has government approval to produce up to 10 tons of flower and 5 tons of oil, said Lewis — who added that he’s asking the Uruguayan government to allow him to grow 15 times that, in order to curb that global market. (He’s also shopping for a “large strategic partner” to provide the estimated $60 million of start-up capital needed to grow all that cannabis.)

If Lewis is right and producers in other companies join in, Fotmer may be well positioned to remain competitive, an outlook shared by other analysts. As New Frontier Data noted in a global market analysis released earlier this year, South America is considered a future hub for cannabis production thanks to an agreeable climate and low labor costs.

If countries decide that domestic suppliers are preferable and throw up tariffs, Lewis’s play could disappear. Or perhaps the best praxis is to play off of the incredible hype around the cannabis industry and get acquired. The point is that in a world obsessed with the next big thing, cannabis is very quickly approaching critical mass, and entrepreneurs are slowly catching on.

CONTINE READING…

Authored By: Cannabis Now

Article category: Marijuana Business News

Amid regulatory uncertainty and global demand, China’s hemp industry is booming

Submitted by Marijuana News on Tue, 10/08/2019 – 10:38

China has a zero tolerance approach to marijuana (along with numerous other drugs), yet surprisingly it is the world’s largest producer of hemp, and also the world’s largest exporter of this increasingly lucrative plant.

While chances of medical marijuana being legalized in China are seemingly next to none, calls for a clear policy when it comes to industrial hemp and CBD products are increasing — as is the plant’s production in the country.

While cannabidiol (CBD) has become as widely proliferated as over-the-counter painkillers in the West, products using this hemp-derived compound have yet to be seen stocking store shelves in China. The plant it originates from, however, has had a far lengthier history. Ma (麻), the Chinese word for hemp, has actually been in use for thousands of years, widely enough that the classic text Book of Odes, or Shi Jing (诗经), contains many references to hemp use in the daily lives of Chinese people from the 11th to 7th century BCE.

The cultivation of hemp was made illegal in 1985, despite China having a long history with the crop. It was only in 2010, after a push by locals, that authorities again allowed it to be grown on an industrial scale in Yunnan province in southwest China.

Marijuana plants containing the psychoactive agent tetrahydrocannabinol (THC) are to date resoundingly illegal within China — despite what Randy from South Park might think — but plants containing quantities of CBD fall into a grayer area.

As it stands, companies are allowed to farm industrial hemp in Heilongjiang and Yunnan provinces (in China’s northeast and southwest respectively). China Daily reported early this year that talk of farmers being allowed to grow industrial hemp in Jilin province (next door to Heilongjiang), which had begun in 2017, had proven fruitful. Additional sources attest that hemp is also legally being grown in regions such as Anhui, Gansu, and Xinjiang.

Figures provided on Hanma Industrial Group Co. Ltd.’s website — one of China’s leading hemp producers — show that half a million hectares of land were used to grow hemp in Anhui province, close to Shanghai in eastern China, in 2014. Other provinces, excluding Heilongjiang and Yunnan, accounted for 0.4 million hectares. Curiously, many media outlets fail to report these facts.

This confusion as to the location of hemp farms in the country is perhaps related to the distinctions of industrial hemp. Industrial hemp is a marijuana plant (cannabis sativa L. subsp. sativa var. sativa) specifically bred to contain the least amount of THC possible, and has a wide range of applications. Industrial hemp is the most commonly farmed hemp strain, although China is home to hemp plants from 33 families and more than 90 genera, including ramie, flax, jute, kenaf, sisal hemp, and abaca.

With that being said, police have historically targeted marijuana plants grown outside of the industry complex. This year, for instance, authorities eradicated 10,000 wild plants growing alongside the Yongding river in Beijing’s Fengtai district.

The mood at the Industrial Cannabis Forum of Listed Companies in mid-August was pragmatic in the face of such continued confusion over regulations in the industry. Participants called for more clearly defined policies on the issues, while Yuan Hua, general manager of Kunming Pharmaceutical Group, said that China’s cannabis industry will need an additional two to three years’ time to establish itself. Her suggestion for companies in the meantime was “research and development,” in order to create new pharmaceuticals and products and lay the groundwork for the future of the industry.

With the recent rise in products containing CBD around the globe, Chinese hemp farmers and companies have begun to turn their attention to cosmetics, pharmaceuticals, beverages, and other products that use CBD in some form.

Tan Xin, chairman and founder of Hanma Investment Group Co. Ltd., tells us: “We did a lot of research in the early days and saw that investors like Peter Thiel and George Soros had put money into this industry. We believe this business has huge potential.”

As an example of the potential lucrative nature of this industry, consider that July to late September/early October is usually harvesting season for hemp plants in China. As more companies seek to gain a foothold in this fledgling market — and news of developments like the legalization of industrial hemp farming in Jilin province has spread — stock prices for firms such as Dezhan Health and Meiyingsen have soared this year not only during harvest time, but since the beginning of 2019, prompting international media outlets like The New York Times to sit up and take notice.

Yet in a move that perhaps put a damper on the industry, the Chinese National Anti-Drug Committee published a release in mid-March earlier this year re-clarifying the country’s stance on industrial hemp farming. The release plainly stated that CBD is not included on the list of narcotic drugs in the country, and that it is not a controlled drug. It also stated that marijuana with a THC content of 0.3% or less can be grown in certain parts of China. While this release certainly clarified parts of China’s stance on CBD, it was also vague in many areas and had a negative effect on multiple stocks on Chinese exchanges, prompting investors to sell off.

Nonetheless, people like Tan are optimistic about the future of CBD in the country, particularly in the beauty industry. “Nowadays, CBD is considered an ‘all-purpose ingredient’ [for beauty] in the Western world,” says Tan. “It not only has a therapeutic effect on skin diseases, but is also effective in terms of oil control, acne, and skin whitening.

While research and development for all types of products using CBD is technically legal, only beauty products with CBD are legal to sell in China.

“Since 2015, ‘hemp leaf extraction’ can be legally used in cosmetics,” says Tan. “And because the cosmetics industry is so huge in China, we have a good shot in this business.”

He adds however that pharmaceuticals and health products remain the company’s biggest priority at the moment.

All of this points to the crux of China’s argument for the widespread legalization of industrial hemp farming and CBD use in medicine: health.

Many tout the benefits of CBD in treating conditions like epilepsy and Alzheimer’s, as well as providing pain relief, though research on some of these claims is as of yet inconclusive. According to a report by Global Times, China holds 309 of the world’s 606 hemp-related patents, but due to legal restrictions, Chinese-made food and medicine containing CBD can only find a market outside of the country, in places like the US and the EU.

As Tan puts it, “the hemp industry is a health industry. Nothing will keep us from the pursuit of health.”

CONTINUE READING…

Authored By: Radii China


DEA Announces Steps Necessary to Improve Access to Marijuana Research

temporary

FOR IMMEDIATE RELEASE

Monday, August 26, 2019

DEA Announces Steps Necessary to Improve Access to Marijuana Research

The Drug Enforcement Administration today announced that it is moving forward to facilitate and expand scientific and medical research for marijuana in the United States. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. DEA anticipates that registering additional qualified marijuana growers will increase the variety of marijuana available for these purposes.

Over the last two years, the total number of individuals registered by DEA to conduct research with marijuana, marijuana extracts, derivatives and delta-9-tetrahydrocannabinol (THC) has increased by more than 40 percent from 384 in January 2017 to 542 in January 2019. Similarly, in the last two years, DEA has more than doubled the production quota for marijuana each year based on increased usage projections for federally approved research projects.

“I am pleased that DEA is moving forward with its review of applications for those who seek to grow marijuana legally to support research,” said Attorney General William P. Barr.  “The Department of Justice will continue to work with our colleagues at the Department of Health and Human Services and across the Administration to improve research opportunities wherever we can.”

“DEA is making progress in the program to register additional marijuana growers for federally authorized research, and will work with other relevant federal agencies to expedite the necessary next steps,” said DEA Acting Administrator Uttam Dhillon.  “We support additional research into marijuana and its components, and we believe registering more growers will result in researchers having access to a wider variety for study.”

This notice also announces that, as the result of a recent amendment to federal law, certain forms of cannabis no longer require DEA registration to grow or manufacture. The Agriculture Improvement Act of 2018, which was signed into law on Dec. 20, 2018, changed the definition of marijuana to exclude “hemp”—plant material that contains 0.3 percent or less delta-9 THC on a dry weight basis. Accordingly, hemp, including hemp plants and cannabidiol (CBD) preparations at or below the 0.3 percent delta-9 THC threshold, is not a controlled substance, and a DEA registration is not required to grow or research it.

Before making decisions on these pending applications, DEA intends to propose new regulations that will govern the marijuana growers program for scientific and medical research. The new rules will help ensure DEA can evaluate the applications under the applicable legal standard and conform the program to relevant laws. To ensure transparency and public participation, this process will provide applicants and the general public with an opportunity to comment on the regulations that should govern the program of growing marijuana for scientific and medical research.

The Notice of Application is available here: https://www.federalregister.gov/public-inspection/current.

Component(s):

Drug Enforcement Administration (DEA)

Office of the Attorney General

Press Release Number:

19-895

Updated August 26, 2019

SOURCE LINK

DEA affirms hemp’s new status, sends notice that plant is legal

Published August 26, 2019

More than six months after hemp was made legal in the United States, federal drug authorities have updated their guidance to remind law enforcement that hemp is no longer a controlled substance.

A notice posted Monday by the U.S. Drug Enforcement Administration (DEA) cited the 2018 Farm Bill in noting that “certain forms of cannabis no longer require DEA registration to grow or manufacture.”

The agency went on to say that “hemp, including hemp plants and cannabidiol (CBD) preparations at or below the 0.3 percent delta-9 THC threshold is not a controlled substance.”

The DEA notice didn’t change the law or make hemp legal; that occurred last year.

But because the agency had yet to remind national law enforcement through its regular bulletins that hemp is legal, some hemp businesses found themselves fighting legal confusion about the plant’s status.

Attorneys who represent hemp clients told Hemp Industry Daily that the DEA statement is an overdue affirmation of cannabis legality.

The DEA also announced Monday that it will expand research on higher-THC varieties of cannabis classified as marijuana.

CONTINUE READING…

“Any displays, sale or solicitation of CBD oil is illegal and individuals involved are subject to federal investigation and prosecution.”

CBD oil, sold in stores throughout Ohio, is illegal and can carry a felony charge

CBD oil, sold in stores throughout Ohio, is illegal and can carry a felony charge

By Shannon Houser | October 9, 2018 at 9:49 PM EST – Updated October 10 at 11:26 AM

CLEVELAND, OH (WOIO) – CBD oil is available online, in every state and is commonly found on store shelves across Northeast Ohio; however, it’s illegal and can result in a felony charge.

So, why the big confusion over the chemical compound?

“I got pulled over in a traffic stop and long story short, they found CBD oil,” said Robert Faulkner.

It was July of last year when Faulkner was arrested in Richland County.

“I tried it for my anxiety. It didn’t work for me at that particular time and I just threw it in the back on my truck,” he said.

Faulkner said he bought it from a store in Columbus. He said the oil was made and manufactured from a hemp store in Cincinnati.

“I never went to the store and thought I was buying something that would potentially put me in prison,” he said.

Faulkner was slapped with two counts of aggravated possession of drugs. He’s awaiting a grand jury trial for the felony charges.

Here in Ohio, you cannot possess CBD oil. The laws aren’t stopping people from buying it and it’s not stopping stores from selling it.

Faulkner believes the reason is there is so much confusion about the law.

“I didn’t knowingly obtain everything illegal. I went to a store to try to help me with an issue I have,” said Faulkner.

THC is the chemical compound responsible for the high in marijuana. The DEA says they’ve learned through science, that CBD will always contain some amount of THC, even trace amounts that won’t get you high.

But given the presence of THC, the over-the-counter oil is illegal.

Cleveland 19 found two local stores with shelves full of CBD oil.

According to the DEA:

“Any displays, sale or solicitation of CBD oil is illegal and individuals involved are subject to federal investigation and prosecution.”

We found in some states, like in Texas, police are raiding stores who are selling CBD oil.

So why isn’t that happening here if it’s illegal?

The DEA wouldn’t say, but did say stores selling it aren’t immune from federal investigation.

Faulkner says he hopes officials and lawmakers can help make the laws more clear so this doesn’t happen to someone else.

“I have an ankle monitor on right now. I have to go check in with probation. I spent four days in jail. This is impacting my life seriously, for something I bought in at the store to just try to help my anxiety.”

CBD is covered by Ohio’s medical marijuana law–and will be available to those with a medical marijuana card.

The FDA recently approved a CBD oil medication that is used to help treat epilepsy.

It can only be prescribed by licensed doctors.

CONTINUE READING…

RELATED:

Why we must repeal prohibition

What Is Legal and What Is Not??? “I was arrested for multiple felonies…in KNOX County Tennessee for possessing Industrial Hemp”

Pure Spectrum Video

Please view video above.

Following the passing of the 2014 Farm bill, the Kentucky Department of Agriculture launched the Industrial Hemp Research Program that would allow farmers and processors to begin the development of an industry. LINK

There has been some disconcerting news showing up on social      media in the past few days.  It seems the DEA may be trying to push buttons…

They picked the right words for it, “Hemp Research” Bill, because that is exactly what they have been doing since the research       started…using our Farmer’s to start an industry that they damn well knew they would not let them keep for very long.  The idea is to let the Farmer’s do the work for the start-up so that they think that they are accomplishing a great feat, (which they are), and then yank it right out from under them via the DEA and hand it over to the Pharmaceutical Conglomerates where they can make big money by controlling our access to the Cannabis plant.

The fact is that it was not “Marijuana” that they were worried about infiltrating the Nation, it was controlling the Hemp and now the CBD.  Marijuana is just the control button so to speak.

It all comes back around to the NWO and Agenda 21 to control the masses.  (If you control the food – and medicine, you control the people).  But first they want to make sure that everyone wants and/or needs what they are going to take control of.  Once the market starts to bloom, it’s time to take it back.

I first noticed a problem about two months ago when Stripe discontinued merchant services for the U.S. Marijuana Party, stating it was a prohibited business.  I sell nothing but T-Shirts, lol.  I went to my bank and asked them about it and sure enough, they weren’t accepting any “marijuana related” business either.  So, I have no way to sell T-Shirts Laughing out loud online at this time. Unless I want an offshore bank          account!

On July 18th, Brady Bell broke the news that USPS was, as of the 17th “…ceasing all shipping of hemp/CBD products. The inspector said they are going to start confiscating any products that violate their stance…”

PureSpectrum-BradyBell

PureSpectrum-BradyBell2

And so it begins…

Jaime Rothensteinenheimer is feeling heartbroken

I was arrested for multiple felonies at 1pm Wednesday July 18, 2018 in KNOX County Tennessee for possessing Industrial Hemp. My charges are Possession of Sched 6 drugs with Intent to Deliver (marijuana). The COA and 3rd Party Lab Reports were with the hemp products. I was forced to sleep on the porch of a Fireplace Store in Sevierville, TN until the impound opened to retrieve my vehicle. I am being arraigned tomorrow morning at 10am in Knox County Courthouse for Multiple felony charges.

On Wednesday July 18, 2018 at 11am the DEA raided my suppliers warehouses in SC and FL, took controlled samples for testing and went about their business. No charges yet .  On Friday July 20,2018 the Atlantic Beach Police Dept had me sign a form to allow the Search of my business, Terp Market and Lounge, due to the City Commission claiming that “nefarious” characters were coming and going. I complied and the detectives were very polite. It still grinds my gears that we are doing positive things in the community and are getting treated like criminals over a PLANT.     LINK  

No automatic alt text available.



From Brady Bell, of Pure Spectrum CBD, Colorado…

As an industry we have to take a stand. I now know why this is happening. GW Pharmaceuticals are the reason behind this with their lobbying efforts. It’s time the industry takes a stand and we file a class action lawsuit on GW Pharmaceuticals. I have the plan in motion. I will be reaching out to owners and anyone else that wants to join the battle. Feel free to email me, Brady@purespectrumcbd.com. We have the legal team and direction. The rest will require unity. LINK

EVERYONE in the CANNABIS business, whether legal or not, whether it is Hemp or Marijuana/Cannabis that you sell, or USE for medicine or recreationally,  should pay very close attention to what is happening right now.  The quality of Our lives  very much depends upon what happens with Cannabis.

Hemp almost legal as Big Pharma moves in on CBD

Please read the above linked article.

On my end, I am concerned about the control of Cannabis/Hemp and  the regulations which will follow legalization and what it means to the prison industrial complex.  I am concerned about the right to grow a Cannabis plant in my yard and use it personally for medicine and pleasure.  I am concerned about all the children and other people who were so wrongly denied the Cannabis plant since 1937 and before, who so badly needed it as a medication, which was ALREADY IN THE PHARMACOPEIA IN 1900’S, but that the Government pulled out from under them in the name of commerce. 

DEA guidance is clear: Cannabidiol is illegal and always has been

Cannabis, Hemp, Marijuana are all born from the same species.  Don’t let them divide us!

NEVER say legalize!  ALWAYS push for REPEAL of the CANNABIS Plant as a “whole”… 

When it is freed to the People of this Country, and it is no longer a crime to possess or grow on our own property, or use in our own homes, and the Hemp Farmers are free to grow and sell their Hemp plants AND products, then it can be produced by the          Pharma’s as a medication and THEIR products can be labeled as “CONTROLLED SUBSTANCES”!

Until then, Pharma should not be allowed to profit, or produce, any Cannabis medications!

smk

The Kentucky Department of Agriculture (KDA) is conducting an Industrial Hemp Research Pilot Program as authorized by KRS 260.850-260.869, and 7 U.S.C.§ 5940 (also known as Section 7606 of the 2014 Farm Bill).  Industrial hemp plants, leaf, floral materials, and viable seed materials remain a Schedule I Controlled Substance under state and federal law; no person can grow, handle, broker, or process industrial hemp in Kentucky without a license issued by the KDA. For more information on applications, please visit the Applications for the Hemp Program page.  Industrial Hemp is a Controlled Substance and requires a KDA License to Grow, Handle, Process, or Market LINK


Legislative Research: KY SB50 | 2017 | Regular Session

Hemp in Kentucky

Medical Marijuana, Inc. Applauds New Market Opportunities for CBD, U.S. Farmers as Sen. Mitch McConnell Pushes Bill to Legalize Hemp

News provided by   Medical Marijuana, Inc.    09:00 ET

SAN DIEGO, April 13, 2018 /PRNewswire/Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, announced today that the Company applauds U.S. Senate Majority Leader Mitch McConnell’s first public announcement of his intention to remove industrial hemp from the Controlled Substances Act with the introduction of the Hemp Farming Act of 2018.

Previously, McConnell helped develop new federal and state legal permissions for hemp and even steered hemp into the 2014 Farm Bill. Now, according to McConnell’s public senate announcement on Thursday, April 12, the Hemp Farming Act of 2018 would remove hemp with less than 0.3 percent of tetrahydrocannabinol (THC) from the controlled substances list. This would include the de-scheduling of all derivatives, extracts and seeds of hemp as long as those portions of the plant remain below the THC requirement.

“During the recent state work period, I talked to a number of farmers, manufacturers, and small business owners who expressed enthusiasm for hemp’s potential, and I was proud to stand with Kentucky’s Agriculture Commissioner Ryan Quarles to announce the impending introduction of this bill,” said Senate Majority Leader Mitch McConnell in his senate speech.

The bill would also add hemp as an eligible commodity for the purposes of crop insurance. This allows farmers to access capital for cultivation and production of hemp and hemp products. For hemp research and production, the Hemp Farming Act of 2018 would make hemp research eligible for competitive grant funding under the National Agricultural Research, Extension, and Teaching Policy Act of 1977.

“This bill has such widespread bipartisan support that it is not only being considered to be an amendment to the Farm Bill of 2018, but also a unique bill on its own,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It will take a lot of hard work to make hemp federally legal in the U.S., but we’re happy to have someone of such power and influence working to help make this possible.”

Medical Marijuana, Inc. currently produces its full spectrum hemp oil from industrial hemp grown in Europe. If made into law, this new bill could not only generate a major market opportunity for U.S. farmers to potentially source CBD oil for such products from U.S.-based hemp crops, but it could make hemp cultivation legal federally as well, making CBD oil more affordable and accessible for those in need.

Medical Marijuana, Inc. subsidiary HempMeds®, the company that sells the company’s Real Scientific Hemp Oil™ CBD hemp oil, was the first company to ever bring hemp-based CBD oil products to market in the U.S. in 2012 and was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Brazil, Mexico and Paraguay.

CONTINUE READING…

Indiana House votes to allow Hoosier farmers to grow cannabis plants with low THC

2015 451429480-Hemp_Kentucky_NY117_WEB568305.jpg_20150406.jpg

The Indiana House voted unanimously Wednesday for a bill that would allow Hoosier farmers to grow industrial hemp — marijuana’s low-THC cousin.

Under Rep. Jim Lucas’ House Bill 1137, acres of the green leafy plants could be intermingled with rows of corn across family farms in Indiana. Currently only researchers at institutions are allowed to grow the plant, and are unable to do so for commercial purposes. Only Purdue University researchers are growing the product in the state.

The provision could see some push back in the Senate, or from individuals like Attorney General Curtis Hill, who has been outspoken against marijuana legalization.

The Indiana House and Senate appear to be on the same page when it comes to legalizing cannabidiol, a product derived from hemp. However, permitting the growth and manufacturing of hemp would take its legalization a step further.

Many senators were already reluctant to vote for a bill last year that legalized CBD oil for epileptic patients. That measure passed by a 36-13, compared to the unanimous vote in the House.

► More: Holcomb: Indiana stores can continue to sell CBD oil while lawmakers work on fix to law

► More: Indiana takes small step toward legalizing medical marijuana as House votes to study issue

Proponents say House BIll 1137 is a “jobs bill” and could lead to economic growth, while opponents worry about the legality of growing a plant with some similar properties to marijuana.

“Everything I’ve seen says industrial hemp is probably a harmless crop,” Senate leader David Long said. “I have no problem with that, I’m just not sure the federal government issue isn’t still holding us back.”

The federal 2014 farm bill allows states to permit the growth of industrial hemp for research purposes. Kentucky already has a broad industrial hemp pilot program, similar to the pilot program Indiana would begin with this piece of legislation.

Under Kentucky law, farmers can apply for a permit to grow and manufacturer industrial hemp and sell it for various products, such as CBD oil, hemp seed oil and fiber for car manufacturing.

The farm bill permits “marketing research” but also says hemp shouldn’t be grown “for the purpose of general commercial activity.”

The Kentucky Department of Agriculture says its program follows federal law, but others in the industry aren’t so sure.

“There’s been no research that I’ve seen directly,” said Janna Beckerman, a Purdue professor who studies hemp. “It’s sort of a big wink: ‘Oh yea we’re doing research.'”

Indiana would face the same legal question if this bill passes the Senate and is signed into law.

The passage of the law could also be another step towards marijuana legalization, in the eyes of some social conservatives. Already the Indiana House unanimously passed a resolution to study medical marijuana, a unprecedented move for the GOP-led chamber.

The average Hoosier would be unable to differentiate between industrial hemp or marijuana, Beckerman said. Both are leafy and green and both can have a potent smell.

Industrial hemp, however, can’t get users high.

She also said someone could easily hide a marijuana plant in a field of hemp.

Despite legal concerns, Kentucky’s Department of Agriculture has pegged its program as a success. In 2017, Kentucky handlers grew 3,200 acres of hemp in 74 counties. 

“Because of the research conducted by our growers, processors, and universities, I am more optimistic than ever that we can put industrial hemp on a path to widespread commercialization once Congress removes it from the federal list of controlled substances,” Kentucky Agriculture Commissioner Ryan Quarles said in a press release.

Hemp experts say the product could have the same potential in Indiana, once farmers figure out how to properly grow the product.

Indiana is already seen as an agriculture leader and is one of the top 10 agriculture producing states.

“In the long term I think it’s something that will allow our agriculture base to diversify and that’s always a good thing,” Beckerman said. “I think there’s a possibility of different industries developing from this.”

For example FlexForm Technologies, an Elkhart company, manufacturers mats and panel products. Currently the company has to import hemp. That could change if Indiana farmers start growing the product.

Another company, Healthy Hoosier Oil, could use the cold press seed processing they already use to make sunflower seed oil, on hemp seeds to create a food-grade oil.

CBD oil manufacturers could also start using in-state hemp to make their products.

Another issue lawmakers and lobbyist acknowledge they’ll have to solve is educating the public enough to understand the difference between the two plants.

“Industrial hemp has been misaligned with marijuana for the past 70 years or so,” said Justin Swanson, representing Indiana Hemp Industries Association. “It’s time for Indiana’s actions and policies to reflect the fact that industrial hemp is not marijuana and allow the reemerging market to thrive in Indiana once again.”  CONTINUE READING…

Call IndyStar reporter Kaitlin Lange at (317) 432-9270. Follow her on Twitter: @kaitlin_lange.

Hemp Inc. planted hundreds of acres of industrial hemp and high CBD hemp in North Carolina, Kentucky, Colorado, Nevada, and Oregon…

Hemp, Inc. (OTC: HEMP) recently announced that it built the largest commercial industrial hemp processing facility in North America, and the company that intends to “make America hemp again” is now in full operation at its 70,000 square foot facility in Spring Hope, North Carolina.

In addition, August 17 marked the official launch of Hemp Inc.’s NuAxon Tech CO2 Supercritical Extractor. David Schmitt, COO of Industrial Hemp Manufacturing, LLC, said “Hemp, Inc. is now in position to be a fully integrated high quality [cannabidiol] CBD manufacturer,” in a release.

Opening the facility took over three years, plus millions of dollars spent on purchasing, disassembling, transporting, reassembling, rebuilding, refurbishing, beta testing and debugging.

Putting their new extractor to work is a significant step forward in the company’s ability to clone, grow, cultivate and process high CBD plants, with market prices on their side, Schmitt said.

“It basically all boils down to supply and demand. Today, market prices are somewhere in the ballpark of $20,000 per kilo and we have large amounts growing,” said Schmitt.

Hemp Inc. planted hundreds of acres of industrial hemp and high CBD hemp in North Carolina, Kentucky, Colorado, Nevada, and Oregon. The CBD oil industry is expected to reach 1 billion by 2020.

Bruce Perlowin, CEO of Hemp, Inc. CMW Media/Christian Rodas

Bruce Perlowin, CEO of Hemp, Inc. said he intends to create infrastructure for a robust hemp industry by creating a business model of industrial and processing, education, farming, and extraction of CBD oil, so that people can start their own small family hemp farms.

“CBD is the fastest growing sector of the entire medical marijuana and hemp industry,” he said. He said he wants to support anyone who wants a start in the industry on the different technologies available for CO2 extraction, which allows the production of cannabinoid hemp oil.

Hemp, Inc. CEO Bruce Perlowin examines a hemp plant at a North Carolina farm. CMW Media/Christian Rodas

North Carolina Farmer Tony Finch grows hemp at his family farm. CMW Media/Christian Rodas

Perlowin invited President Donald Trump’s task force for Promoting Agriculture and Rural Prosperity in America to see the new hemp facility, saying “President Trump’s Task Force or any member thereof should really visit Hemp, Inc.’s facility in Spring Hope, North Carolina.”

The small family farm, once a staple of the American landscape, is fast disappearing – and Perlowin hopes to change that. He imagines a model family farm is situated on 5 acres and consists of a cloning room, a greenhouse, and 5,000 hemp plants.

“By showing farmers how to grow high CBD hemp plants, operate a greenhouse and turn a barn into a cloning room to earn $500,000 a year, the small family farm can reappear in the American landscape. After all, the original small family farms in America were able to survive economically by growing hemp as their main cash crop and the first five presidents of the United States were all hemp farmers. Our infrastructure is 100 percent aligned with what the President today, is trying to accomplish with this Task Force.”

CONTINUE READING…

This Pharmaceutical Company Wants To Prove Cannabis Destroys Cancer

TREE

Submitted by Marijuana News on Wed, 06/07/2017 – 08:25

CURE Pharmaceutical, a technologically-based drug delivery platform and its partner, Technion-Israel Institute of Technology will be conducting a clinical study to test whether cannabinoid compounds will reduce or eliminate cancerous cells.

Can cannabis really make cancer disappear?

Cannabis as a cancer treatment not only for it symptoms but as a possible cure has been hotly debated and researched for some time.

Federally, the government does accept that cancer-related side effects such as decreased appetite, nausea and pain relief can be treated with cannabis, but as for cancer itself, patients and those in the medical field have only been able to anecdotally link cannabis to the destruction of cancerous cells and tumors.

CURE Pharmaceutical is researching this link head on, in its first ever clinical study of this nature. Brian Higuera, the father of a 4-year-old liver cancer patient says there’s a strong possibility after he witnessed the shrinking of his daughter’s liver tumors, along with one that fully disappeared; all after being administered CBD oil.

The tumors are believed to have been removed due to her cannabis use in which [a brand of] CBD (called Real Scientific Hemp Oil) was a major portion of the cannabinoids in her oil along with THC and CBN.

[But] without a study to prove the cannabis oil is what cause the tumors to disappear, many say she is an anecdotal testimony.

CURE’s CEO, Rob Davidson looks to move beyond the anecdotal stage and provide solid proof to back up cases like Sadie’s. His goal is to prove the efficacy of cannabis with hard science behind it.

There is strong anecdotal evidence, but we want to put some science into it. First, we’ll do an in vitro study and see the effects on cancer cells. We can get into human trials pretty quickly in Israel.

Getting doctors onboard

Much of the reason that cannabis is kept from many patients is due to its federally illegal status. For this reason, not only is cannabis testing for cancer treatment sparsely conducted, but many physicians are left unable to prescribe cannabis legally.

Former Chief Resident at Los Angeles Children’s Hospital, Bonnie Goldstein says that studies like the one conducted by CURE can be highly beneficial in helping doctors prescribe cannabis to patients.

I currently take care of many patients, both adults and children, that have life-threatening advanced cancers and so far, I have been unable to match cannabis treatment to the patient’s specific cancer sub-type.

Initial studies show that different cancers respond to the anti-neoplastic effects of different cannabinoids. This research will answer this question and will allow physicians like myself to tailor treatment for cancer patients.

The study comes on the heels of CUREs announcement that the company will be entering the pharmaceutical cannabis sector. If so, many more studies that prove cannabis’ effects as a cure could be on the horizon and can appeal to many more in the medical profession who wish for more options to successfully treat patients.

CONTINUE READING…